These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26931794)

  • 61. Assessment of radiotherapy combined with adjuvant chemotherapy in the treatment of patients with advanced nasopharyngeal carcinoma: a prospective study.
    Kong F; Cai B; Lin S; Zhang J; Wang Y; Fu Q
    J BUON; 2015; 20(1):206-11. PubMed ID: 25778317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
    Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study.
    Xu T; Liu Y; Dou S; Li F; Guan X; Zhu G
    Oral Oncol; 2015 Sep; 51(9):875-9. PubMed ID: 26163437
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Efficacy of Yanshu injection (a compound Chinese traditional medicine) combined with concurrent radiochemotherapy in patients with stage III nasopharyngeal carcinoma].
    Wei R; Yang DY; Jiang WZ; Dai YY; Wan LY; Yang Z
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):391-4. PubMed ID: 21875474
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Observation on the changes in nasopharyngeal carcinoma patients' olfactory before and after radiotherapy].
    Qiu Q; Chen S; Meng C; Liao F; Huang X; Li T
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):57-8. PubMed ID: 12541862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Concurrent chemotherapy with different dose regimens of cisplatin for nasopharyngeal carcinoma using intensity-modulated radiation therapy: a phase II prospective randomized controlled trial].
    Liu S; Han F; Chen C; Zeng L; Sun X; Lu T
    Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):778-82. PubMed ID: 25567311
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Phase II Clinical Trial of Concurrent Helical Tomotherapy plus Cetuximab Followed by Adjuvant Chemotherapy with Cisplatin and Docetaxel for Locally Advanced Nasopharyngeal Carcinoma.
    Zhang X; Du L; Zhao F; Wang Q; Yang S; Ma L
    Int J Biol Sci; 2016; 12(4):446-53. PubMed ID: 27019628
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
    Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
    Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
    Zeng Q; Wang J; Lv X; Li J; Yin LJ; Xiang YQ; Guo X
    BMC Cancer; 2016 Aug; 16(1):693. PubMed ID: 27577729
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Zhang J; Chen S; Li G; Zhang W; Qin T; Yin P; Huang H; Jiang H
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1087-1097. PubMed ID: 28429051
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factors affecting outcomes of alternating chemoradiotherapy for nasopharyngeal cancer.
    Ueno T; Endo K; Kondo S; Wakisaka N; Murono S; Ito M; Yoshizaki T
    Ann Otol Rhinol Laryngol; 2014 Jul; 123(7):509-16. PubMed ID: 24634152
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of olfactory and trigeminal function using chemosensory event-related potentials.
    Rombaux P; Mouraux A; Bertrand B; Guerit JM; Hummel T
    Neurophysiol Clin; 2006; 36(2):53-62. PubMed ID: 16844543
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Separating normosmic and anosmic patients based on entropy evaluation of olfactory event-related potentials.
    Güdücü C; Olcay BO; Schäfer L; Aziz M; Schriever VA; Özgören M; Hummel T
    Brain Res; 2019 Apr; 1708():78-83. PubMed ID: 30537519
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Olfactory function in patients with ischemic stroke: a pilot study.
    Cecchini MP; Bojanowski V; Bodechtel U; Hummel T; Hähner A
    Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1149-53. PubMed ID: 22042242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic value of olfactory evoked potentials in patients with post-infectious olfactory dysfunction.
    Guo Y; Wu D; Sun Z; Yao L; Liu J; Wei Y
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3839-3846. PubMed ID: 33644842
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Chemosensory evoked potentials. Applications and significance in routine clinical practice].
    Welge-Lüssen A
    HNO; 1999 May; 47(5):453-5. PubMed ID: 10412652
    [No Abstract]   [Full Text] [Related]  

  • 77. Olfactory event-related potentials in a functionally anosmic patient with arrested hydrocephalus.
    Caminiti F; Ciurleo R; De Salvo S; Galletti F; Bramanti P; Marino S
    J Int Med Res; 2019 Mar; 47(3):1353-1358. PubMed ID: 30732509
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Change in olfaction after radiotherapy for nasopharyngeal cancer--a prospective study.
    Ho WK; Kwong DL; Wei WI; Sham JS
    Am J Otolaryngol; 2002; 23(4):209-14. PubMed ID: 12105785
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
    McDowell LJ; Jacobson MC; Levin W
    Head Neck; 2017 Feb; 39(2):E23-E28. PubMed ID: 27704653
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Individual significance of olfaction: development of a questionnaire.
    Croy I; Buschhüter D; Seo HS; Negoias S; Hummel T
    Eur Arch Otorhinolaryngol; 2010 Jan; 267(1):67-71. PubMed ID: 19626331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.